BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Circassia Limited 



London      United Kingdom
Phone: N/A Fax:


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/13/2014 7:33:24 AM    More...
Circassia Limited Seeks $285 Million In One Of Europe's Biggest Biotech IPOs 2/6/2014 7:07:24 AM    More...
Circassia Limited Appoints Paul R Edick to Its Board of Directors 10/17/2013 10:01:07 AM    More...
Circassia Limited's Grass Allergy Treatment Achieves Significant Symptom Reduction During Hay Fever Season 10/1/2013 9:20:45 AM    More...
Circassia Limited Appoints Dr. Francesco Granata as Chairman 9/25/2013 8:46:38 AM    More...
Circassia Limited's Short-Course House Dust Mite Allergy Treatment Achieves Significant Long-Term Symptom Reduction 9/12/2013 9:26:05 AM    More...
Circassia Limited's Cat Allergy Treatment Shows Sustained Symptom Improvement 2/25/2013 10:53:48 AM    More...
Circassia Limited Appoints Dr Jean-Jacques Garaud to Its Board of Directors 12/6/2012 12:34:22 PM    More...
Circassia Limited Initiates Pivotal Phase 3 ToleroMune® Trial in Cat Allergen-Induced Rhinoconjunctivitis 10/4/2012 10:29:17 AM    More...
Circassia Limited Announces Publication of ToleroMune® Cat Allergy Treatment Clinical Results in Journal of Allergy and Clinical Immunology 9/27/2012 10:06:51 AM    More...
1234